FuturHealth

About FuturHealth

FuturHealth has emerged as one of the dominant forces in the GLP-1 telehealth industry, and the data behind that position is staggering. Founded in 2021, the platform has served over 1.5 million patients and accumulated more than 15,750 reviews on Trustpilot with a 4.7-star rating. These are not just impressive numbers — they represent the largest verified review corpus of any GLP-1 telehealth provider we have evaluated, and the near-perfect rating at that scale is remarkable.

The clinical model at FuturHealth goes well beyond basic prescribing. The platform includes lab testing covering 8 biomarkers as part of its standard program, providing meaningful insight into each patient’s metabolic health before and during treatment. FuturHealth also offers access to registered dietitians along with structured meal plans, creating the kind of integrated approach that maximizes the effectiveness of GLP-1 medications. This combination of medication management, laboratory monitoring, and nutritional support puts FuturHealth in elite company among telehealth providers.

Perhaps the most distinctive feature of FuturHealth’s offering is its 10% weight loss guarantee with a money-back promise. This is an extraordinary commitment that we have not seen from any other provider in our review database. It signals deep confidence in the platform’s clinical model and medication efficacy, and it materially reduces the financial risk for patients who are investing in GLP-1 therapy for the first time. The guarantee transforms the value proposition from “try and hope” to “results or your money back” — a powerful differentiator in a crowded market.

FuturHealth offers both brand-name Ozempic and Wegovy as well as compounded semaglutide, with pricing from $99-$399 per month. This range accommodates patients at different budget levels while maintaining access to the clinical support infrastructure. The Trustpilot profile consistently shows patients praising the quality of medical consultations, the responsiveness of support staff, and the effectiveness of the program overall. Maintaining a 4.7-star average across more than 15,000 reviews requires consistently excellent execution at massive scale.

The platform does not currently have a Better Business Bureau listing, and it does not accept insurance — two areas where there is room for growth. However, these are relatively minor gaps in the context of FuturHealth’s overall offering. With its enormous patient base, industry-leading review profile, comprehensive clinical model including 8-biomarker lab testing and dietitian support, and a unique money-back weight loss guarantee, FuturHealth delivers one of the most compelling and well-validated GLP-1 telehealth experiences available. It narrowly misses our top score only because of the insurance and BBB gaps.

FuturHealth GLP-1 Medications

At a Glance